EBTs hold the promise of providing the next major breakthrough in the management of obesity. At a time when less than 1% of qualified patients actually undergo bariatric surgery, the development of a variety of new endoscopic therapies that replicate the physiological benefits of bariatric surgery in a safe, cost-effective, and minimally invasive fashion may potentially offer the best path to making a meaningful impact on the obesity epidemic. Currently investigated devices have established promising outcomes in short-term weight loss and in control of the metabolic and other medical adverse events of obesity. Pending regulatory approval in the United States, further studies will help define their optimal role in the comprehensive management of obesity.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging